These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17440154)

  • 1. FDA clarifies rules for getting experimental drugs.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Apr; 99(8):584-5, 589. PubMed ID: 17440154
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
    AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
    Arbuckle RB; Griffith NL; Iacovelli LM; Johnson PE; Jorgenson JA; Kloth DD; Lucarelli CD; Muller RJ
    Pharmacotherapy; 2008 May; 28(5 Pt 2):1S-15S. PubMed ID: 18447704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
    Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
    Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New FDA policy encourages inclusion of women in clinical trials.
    Clin Pharm; 1993 Oct; 12(10):712-3. PubMed ID: 8258252
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA licensure of NEUMEGA to prevent severe chemotherapy-induced thrombocytopenia.
    Kaye JA
    Stem Cells; 1998; 16 Suppl 2():207-23. PubMed ID: 11012193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA policy on women in drug trials.
    Caschetta MB; Chavkin W; McGovern T
    N Engl J Med; 1993 Dec; 329(24):1815-6. PubMed ID: 8232495
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA launches "new use initiative".
    Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trials and tribulations.
    Nat Rev Drug Discov; 2007 May; 6(5):331. PubMed ID: 17539051
    [No Abstract]   [Full Text] [Related]  

  • 12. New initiatives aim to test more cancer drugs for children.
    Brower V
    J Natl Cancer Inst; 2004 Dec; 96(24):1808-10. PubMed ID: 15601634
    [No Abstract]   [Full Text] [Related]  

  • 13. Unproven methods of cancer treatment: H.11.
    CA Cancer J Clin; 1970; 20(3):172-5. PubMed ID: 4988623
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products.
    Rock EP; Scott JA; Kennedy DL; Sridhara R; Pazdur R; Burke LB
    J Natl Cancer Inst Monogr; 2007; (37):27-30. PubMed ID: 17951228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ODAC Chronicles: Part 4. Hurdles pre and post accelerated approval.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):197-200. PubMed ID: 15877516
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted agents: the rules of combination.
    Kwak EL; Clark JW; Chabner B
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA starts moving on critical path, but initiative running out of steam.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Mar; 99(6):426-7. PubMed ID: 17374831
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor progression associated with erythropoiesis-stimulating agents.
    Newland AM; Black CD
    Ann Pharmacother; 2008 Dec; 42(12):1865-70. PubMed ID: 19017828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint FDA, NCI program aims to streamline cancer drug development.
    FDA Consum; 2003; 37(4):11. PubMed ID: 12971341
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial for the Food and Drug Administration's clinical trial process.
    Madden BJ
    Cancer Biother Radiopharm; 2005 Dec; 20(6):569-78. PubMed ID: 16398609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.